Objective: To compare lidocaine levels after administration through an
IV line, a standard endotracheal (ET) tube, and an ET tube side port
(ETSP) designed for medication administration. Methods: A double-blind
, prospective, triple crossover canine study was performed, Seventeen
anesthetized mongrel dogs were given standard doses of 2% lidocaine vi
a IV (1.5 mg/kg), endotracheally through the main lumen (3 mg/kg dilut
ed in 10 mL normal saline), and endotracheally through the modified si
de port (3 mg/kg diluted in 10 mL normal saline), Arterial blood gases
(ABGs) and plasma lidocaine levels were measured at time 0, 30 sec, 1
min, 5 min, 10 min, 20 min, 30 min, and 60 min. Mean lidocaine levels
across time, comparing the 3 methods of administration, were analyzed
with repeated-measures analysis of variance. The main outcome was the
comparison of mean ET and ETSP lidocaine levels at each time point us
ing paired t-tests. The attainment and duration of lidocaine levels co
nsidered therapeutic in cardiac arrest (1.4 mu g/mL) were described, A
BGs were measured at each point to describe trends in oxygenation. Res
ults: Mean lidocaine levels, comparing the 3 methods of administration
, were significantly different at all time points except time 0. The E
TSP levels were significantly lower than the ET main-lumen levels at 3
0 sec, 1 min, 5 min, and 10 min. IV-administered lidocaine attained qu
ick therapeutic levels and revealed faster elimination. Lidocaine admi
nistered through the ET main lumen reached therapeutic levels more slo
wly, and maintained such levels longer. Lidocaine administered through
the ETSP never reached therapeutic levels, Mean PO(2)s remained >340
torr throughout each method of administration. Conclusion: This nonarr
est canine model suggests that lidocaine levels achieved through an ET
SP are lower than levels obtained with the same drug dose via an ET ma
in lumen. Therapeutic lidocaine levels are obtainable by IV or ET main
-lumen routes, but not via this ETSP.